[1]孙 莹,王惠萍,段丽芬,等.小儿智力糖浆联合阿立哌唑治疗儿童抽动障碍的疗效及其对免疫功能的影响[J].医学信息,2019,(20):139-141.[doi:10.3969/j.issn.1006-1959.2019.20.043]
 SUN Ying,WANG Hui-ping,DUAN Li-fen,et al.Therapeutic Effect of Pediatric Intellectual Syrup Combined with Aripiprazole on Children with Tic Disorder and its Effect on Immune Function[J].Medical Information,2019,(20):139-141.[doi:10.3969/j.issn.1006-1959.2019.20.043]
点击复制

小儿智力糖浆联合阿立哌唑治疗儿童抽动障碍的疗效及其对免疫功能的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年20期
页码:
139-141
栏目:
药物与临床
出版日期:
2019-10-15

文章信息/Info

Title:
Therapeutic Effect of Pediatric Intellectual Syrup Combined with Aripiprazole on Children with Tic Disorder and its Effect on Immune Function
文章编号:
1006-1959(2019)20-0139-03
作者:
孙 莹王惠萍段丽芬王春霞张 霞郑宇霞王左华罗 超
(云南省昆明市儿童医院神经内科,云南 昆明 650034)
Author(s):
SUN YingWANG Hui-pingDUAN Li-fenWANG Chun-xiaZHANG XiaZHENG Yu-xiaWANG Zuo-huaLUO Chao
(Department of Neurology,Children's Hospital of Kunming,Kunming 650034,Yunnan,China)
关键词:
小儿智力糖浆阿立哌唑儿童抽动障碍免疫功能
Keywords:
Children's intelligence syrupAripiprazoleChildren with tic disorderImmune function
分类号:
R749.94
DOI:
10.3969/j.issn.1006-1959.2019.20.043
文献标志码:
A
摘要:
目的 探究小儿智力糖浆联合阿立哌唑治疗儿童抽动障碍的临床疗效及其对儿童免疫功能的影响。方法 选择我院儿科2017年1月~2018年1月收治的64例抽动障碍患儿作为研究对象,按照随机数字表法分为观察组和对照组,各32例。对照组采用阿立哌唑治疗,观察组在对照组基础上联合小儿智力糖浆治疗,比较两组患儿外周T淋巴细胞亚群及血清免疫球蛋白(Ig)水平、耶鲁综合抽动严重程度量表评分(YGTSS)、注意力缺陷多动障碍评分量表评分(ADHD)及临床疗效。结果 观察组运动抽动、发声抽动、功能受损程度及抽动总分均低于对照组,差异有统计学意义(P<0.05);观察组注意力缺陷、多动冲动及ADHD总分低于对照组,差异有统计学意义(P<0.05);观察组治疗总有效率为96.87%,高于对照组的75.00%,差异有统计学意义(P<0.05);观察组外周血CD3、CD4、CD4/CD8、IgG及IgA均高于对照组,差异具有统计学意义(P<0.05);两组外周血CD8及IgM比较,差异无统计学意义(P>0.05)。结论 小儿智力糖浆联合阿立哌唑可有效改善儿童抽动障碍的临床症状和免疫功能,效果优于单用阿立哌唑,临床疗效确切。
Abstract:
Objective To investigate the clinical efficacy of pediatric intellectual syrup combined with aripiprazole in the treatment of children with tic disorder and its effect on children's immune function. Methods 64 children with tic disorder admitted to our hospital from January 2017 to January 2018 were enrolled in the study. According to the random number table, the observation group and the control group were divided into 32 cases. The control group was treated with aripiprazole. The observation group was treated with pediatric intellectual syrup on the basis of the control group. The peripheral fasting blood was taken to detect the peripheral T lymphocyte subsets and serum immunoglobulin (Ig) levels.The Yale Comprehensive Tic Severity Scale Scale (YGTSS), Attention Deficit Hyperactivity Disorder Rating Scale (ADHD) and clinical outcome were compared between two groups. Results The twitching, vocal twitching, functional impairment and twitching scores of the observation group were lower than the control group,the difference was statistically significant (P<0.05). The attention deficit, hyperactivity impulse and total ADHD scores in the observation group were lower than the control group,the difference was statistically significant (P<0.05). The total effective rate of the observation group was 96.87%, which was higher than that of the control group 75.00%,the difference was statistically significant (P<0.05). The peripheral blood CD3, CD4, CD4/CD8, IgG and IgA were higher than the control group, the difference was statistically significant (P<0.05). There was no significant difference in CD8 and IgM between the two groups (P>0.05). Conclusion Infant intelligence syrup combined with aripiprazole can effectively improve the clinical symptoms and immune function of children with tic disorder. The effect is better than aripiprazole alone. The clinical effect is exact.

参考文献/References:

[1]邱金花,孟令丹,马良,等.乌灵胶囊联合阿立哌唑治疗儿童慢性抽动障碍的效果分析[J].中国妇幼保健,2016,31(24):5398-5400. [2]Fleischhacker WW,Sanchez R,Perry PP,et al.Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study[J].British Journal of Psychiatry,2018,205(2):135-144. [3]吴传军,陈燕惠.经颅微电流刺激与阿立哌唑治疗儿童抽动障碍的对照研究[J].中国儿童保健杂志,2016,24(6):576-578. [4]Potkin S,Schmidt SN,Salzman P,et al.Effect sizes of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia:a post-hoc analysis of Qualify[J].European Neuropsychopharmacology,2016,26(2):S564-S565. [5]蔡晓楠,何学莲,吴革菲,等.阿立哌唑治疗儿童Tourette综合征的疗效及安全性分析[J].中华实用儿科临床杂志,2016,31(18):1426-1431. [6]Ghanizadeh A.Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial[J].Annals of General Psychiatry,2016,15(1):21. [7]姜琳.托莫西汀和阿立哌唑治疗儿童注意缺陷多动障碍的疗效比较[J].现代药物与临床,2017,32(2):245-248. [8]Wang S,Wei YZ,Yang JH,et al.The efficacy and safety of aripiprazole for tic disorders in children and adolescents:A systematic review and meta-analysis[J].Psychiatry Research,2017(254):24-32. [9]朱彦丽,王立文,彭晓音,等.不同剂量阿立哌唑治疗儿童Tourette综合征的长期疗效及安全性研究[J].北京医学,2017,39(7):674-677. [10]Chandradasa M,Champika L.The use of aripiprazole for tic disorders in children and adolescents and implications for resource limited settings in the developing world[J].Psychiatry Research,2017,29(263):298. [11]姜淑珍,闫琨,傅勇辉,等.阿立哌唑治疗儿童青少年精神分裂症的血药浓度与临床疗效分析[J].国际精神病学杂志,2017(6):987-990. [12]Pozzi M,Pisano S,Bertella S,et al.Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison[J].Journal of Clinical Psychiatry,2016,77(12):e1601. [13]赵欣,吴敏,张欣,等.抽动障碍药物治疗现状分析[J].国际精神病学杂志,2016(4):617-619. [14]Brasas FDLT,Domínguez AD,Hernández NE,et al.Hoarding disorder and obsessive-compulsive disorder[J].European Psychiatry,2016(33):S350. [15]纪小艺,吴敏.抽动障碍患儿治疗前后多巴胺D2受体与转运体mRNA的表达[J].中国当代儿科杂志,2016,18(4):297-300. [16]何玉琼,刘剑波,孟甜甜,等.小儿智力糖浆治疗儿童注意缺陷多动障碍疗效和安全性的多中心临床观察[J].中华实用儿科临床杂志,2017,32(17):1331-1334.

相似文献/References:

[1]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
 WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,(20):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]

更新日期/Last Update: 2019-10-15